Global Gene Amplification Technologies Market : Industry Analysis and Forecast (2022-2029)


Global Gene Amplification Technologies Market is expected to reach US$ 32.86 Bn. at a CAGR of 2.3% during the forecast period 2029.

Global Gene Amplification Technologies Market Overview:

DNA amplification and detection technologies developed in the last decade can be used to diagnose and treat a wide range of infectious disorders. The polymerase chain reaction is the most extensively utilized of these procedures (PCR). Many diagnostic laboratories now utilize commercial PCR kits to diagnose TB and genital C. trachomatis infection. Antimicrobial resistance assays have also been created and are used to determine the source of infection by organisms that cannot be cultured.

The importance of viral load detection by nucleic acid amplification in the treatment of patients with HIV or hepatitis C is also well recognized. However, demonstrations of this technique for quick microbiological identification have been hampered by small sample sizes, and the cost of these tests can reach $125 per test. As nucleic acid amplification technologies advance, their function in the diagnosis and management of infectious disease patients, as well as their influence on clinical outcomes is expected to grow significantly during the forecast period.

Major Key Players in the Gene Amplification Technologies Market are identified through secondary research and their market revenues are determined through primary and secondary research. Secondary research included a review of annual and financial reports of leading manufacturers, while primary research included interviews with important opinion leaders and industry experts such as skilled front-line personnel, entrepreneurs, and marketing professionals. Some of the leading key players in the global Gene Amplification Technologies Market include Abbott Laboratories, Cepheid, Agilent Technologies, ID Biomedical Corporation, and Molecular Sensing PLC. They are continuously strategizing on mergers and acquisitions, strategic alliances, joint ventures, and partnerships for the growth of their market shares.

Gene Amplification Technologies Market

To Know About The Research Methodology :- Request Free Sample Report

Global Gene Amplification Technologies Market Dynamics:

Adoption of gene amplification kits in targeted cancer therapies is expected to drive the market growth.

The global Gene Amplification Market is driven by many factors like growing R&D in the field of molecular diagnostics, genetic testing, biological research, drug discovery, bioremediation, toxicology, quality control in the food industry, and forensics. Molecular diagnostics and Human Genome Project are the primary driving factors as they are considered as an international research effort to sequence all the chemical base pairs that form the DNA of the species Homo sapiens. On-going the pandemic of COVID-19 has fuelled the gene amplification market. Diagnostic and antibody tests hold a critical role in identifying people infected with COVID-19. Molecular diagnostic tests available in the market rely on RT-PCR technology to target specific genomic parts of the virus for accurate, reliable detection. PCR-based techniques are capable of detecting low quantities of viral RNA to deliver high sensitivity and allow timely diagnosis of the COVID-19 infection.

The report has profiled nineteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Gene Amplification Technologies Market Segment Analysis:

The Global Gene Amplification Technologies Market is segmented on the basis of Technology and Application.

Based on Technology, the Polymerase Chain Reaction (PCR) holds a dominant share as it remains the most commonly used and effective technology. The technology allows amplification of genetic material in large quantities and is cost-effective & has a rapid turnover rate. PCR technology is playing a prominent role amidst the COVID-19 pandemic as it used to perform molecular diasgnostic tests and antibody tests to identify a person infected with the virus.

Gene Amplification Technologies Market

Global Gene Amplification Technologies Market Regional Insights:

North America is expected to account for the prominent market share during forecast period.

North America held largest market share xx % of the market owing to high investments in healthcare infrastructures, ongoing technological advancements, government funding, and research activities in the field of genetic testing diagnostics, and detection of critical diseases. This region is expected to maintain its dominance over the forecast period with a lucrative growth rate. The market also stands to benefit from the growing popularity of molecular diagnostics for cancer screening and infectious disease testing such as hepatitis B and C, HIV, flu virus, and human papillomavirus. According to the W.H.O, more than 10 million people are expected to die of cancer by the year 2029.

Gene Amplification Technologies MarketThe report also helps in understanding Global Gene Amplification Technologies Market dynamics, structure by analyzing the market segments and project the Global Gene Amplification Technologies Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Gene Amplification Technologies Market make the report investor’s guide.

Global Gene Amplification Technologies Market Scope: Inquire before buying


Global Gene Amplification Technologies Market, by Technology

• Polymerase Chain Reaction (PCR)
• Loop Mediated Isothermal Amplification (LAMP)
• Other

Global Gene Amplification Technologies Market, by Application

• Medical
• Forensics
• Paternity
• Food Safety
• Agri-Diagnostics
• Veterinary

Global Gene Amplification Technologies Market, by Region:

• North America
• Europe
• South America
• MEA
• APAC

Global Gene Amplification Technologies Market, Key players:

• Abbott Laboratories
• Cepheid, Agilent Technologies
• ID Biomedical Corporation
• Molecular Sensing PLC
• Orchid Biosciences Inc.
• Rubicon Genomics
• U.S. Genomics
• Agilent Technologies Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• PerkinElmer Inc.
• QIAGEN Group
• Takara Bio, Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Becton, Dickinson, and Co.
• Bayer Corporation

Frequently Asked Questions:

1. Which region has the largest share in Global Gene Amplification Technologies Market?
Ans: North America region held the highest share in 2021.

2. What is the growth rate of Global Gene Amplification Technologies Market?
Ans: The Global Gene Amplification Technologies Market is growing at a CAGR of 2.3% during forecasting period 2022-2029.

3. What is scope of the Global Gene Amplification Technologies market report?
Ans: Global Gene Amplification Technologies Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Gene Amplification Technologies market?
Ans: The important key players in the Global Gene Amplification Technologies Market are – Abbott Laboratories, Cepheid, Agilent Technologies, ID Biomedical Corporation, Molecular Sensing PLC, Orchid Biosciences Inc., Rubicon Genomics, U.S. Genomics, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Takara Bio, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Becton, Dickinson, and Co., and Bayer Corporation

5. What is the study period of this market?
Ans: The Global Gene Amplification Technologies Market is studied from 2021 to 2029. 





Global Gene Amplification Technologies Market

1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Gene Amplification Technologies Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2021
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Gene Amplification Technologies Market
3.4. Geographical Snapshot of the Gene Amplification Technologies Market, By Manufacturer share

4. Global Gene Amplification Technologies Market Overview, 2021-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Gene Amplification Technologies Market

5. Supply Side and Demand Side Indicators

6. Global Gene Amplification Technologies Market Analysis and Forecast, 2021-2029
6.1. Global Gene Amplification Technologies Market Size & Y-o-Y Growth Analysis.

7. Global Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
7.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
7.1.1. Polymerase Chain Reaction (PCR)
7.1.2. Loop Mediated Isothermal Amplification (LAMP)
7.1.3. Other
7.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029
7.2.1. Medical
7.2.2. Forensics
7.2.3. Paternity
7.2.4. Food Safety
7.2.5. Agri-Diagnostics
7.2.6. Veterinary

8. Global Gene Amplification Technologies Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America

9. North America Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
9.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
9.1.1. Polymerase Chain Reaction (PCR)
9.1.2. Loop Mediated Isothermal Amplification (LAMP)
9.1.3. Other
9.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029
9.2.1. Medical
9.2.2. Forensics
9.2.3. Paternity
9.2.4. Food Safety
9.2.5. Agri-Diagnostics
9.2.6. Veterinary

10. North America Gene Amplification Technologies Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico

11. U.S. Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
11.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
11.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

12. Canada Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
12.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
12.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

13. Mexico Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
13.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
13.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

14. Europe Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
14.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
14.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

15. Europe Gene Amplification Technologies Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe

16. U.K. Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
16.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
16.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

17. France Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
17.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
17.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

18. Germany Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
18.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
18.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

19. Italy Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
19.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
19.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

20. Spain Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
20.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
20.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

21. Sweden Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
21.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
21.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

22. CIS Countries Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
22.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
22.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

23. Rest of Europe Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
23.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
23.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

24. Asia Pacific Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
24.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
24.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

25. Asia Pacific Gene Amplification Technologies Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific

26. China Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
26.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
26.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

27. India Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
27.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
27.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

28. Japan Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
28.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
28.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

29. South Korea Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
29.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
29.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

30. Australia Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
30.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
30.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

31. ASEAN Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
31.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
31.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

32. Rest of Asia Pacific Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
32.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
32.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

33. Middle East Africa Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
33.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
33.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

34. Middle East Africa Gene Amplification Technologies Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A

35. South Africa Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
35.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
35.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

36. GCC Countries Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
36.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
36.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

37. Egypt Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
37.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
37.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

38. Nigeria Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
38.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
38.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

39. Rest of ME&A Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
39.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
39.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

40. South America Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
40.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
40.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

41. South America Gene Amplification Technologies Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America

42. Brazil Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
42.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
42.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

43. Argentina Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
43.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
43.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

44. Rest of South America Gene Amplification Technologies Market Analysis and Forecasts, 2021-2029
44.1. Market Size (Value) Estimates & Forecast By Technology, 2021-2029
44.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029

45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Gene Amplification Technologies Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. Abbott Laboratories
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Cepheid, Agilent Technologies
45.3.3. ID Biomedical Corporation
45.3.4. Molecular Sensing PLC
45.3.5. Orchid Biosciences Inc.
45.3.6. Rubicon Genomics
45.3.7. U.S. Genomics
45.3.8. Agilent Technologies Inc.
45.3.9. bioMérieux SA
45.3.10. Bio-Rad Laboratories Inc.
45.3.11. F. Hoffmann-La Roche Ltd.
45.3.12. Merck KGaA
45.3.13. PerkinElmer Inc.
45.3.14. QIAGEN Group
45.3.15. Takara Bio, Inc.
45.3.16. Siemens Healthineers AG
45.3.17. Thermo Fisher Scientific Inc.
45.3.18. Becton, Dickinson, and Co.
45.3.19. Bayer Corporation
45.3.20. Others

46. Primary Key Insights
  • INQUIRE BEFORE BUYING